norfluoxetine has been researched along with Anxiety in 5 studies
norfluoxetine: metabolite of fluoxetine; RN given refers to parent cpd without isomeric designation
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluoxetine treatment reversed MDMA-induced anxiety in the emergence test and depressive-like effects in the forced swim test, yet exhibited no effects on the social interaction test." | 5.32 | Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats. ( Clemens, KJ; Cornish, JL; Gurtman, CG; Hunt, GE; Li, KM; McGregor, IS; Thompson, MR, 2004) |
| " Fluoxetine and its metabolite, norfluoxetine, were quantified in the plasma of individual fish and linked to behavioural anxiety-related endpoints." | 3.80 | Quantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetine. ( Cumming, RI; de Polo, A; Margiotta-Casaluci, L; Owen, SF; Panter, GH; Rand-Weaver, M; Sumpter, JP; Winter, MJ, 2014) |
| "Fluoxetine treatment reversed MDMA-induced anxiety in the emergence test and depressive-like effects in the forced swim test, yet exhibited no effects on the social interaction test." | 1.32 | Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats. ( Clemens, KJ; Cornish, JL; Gurtman, CG; Hunt, GE; Li, KM; McGregor, IS; Thompson, MR, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sagahón-Azúa, J | 1 |
| Medellín-Garibay, SE | 1 |
| Chávez-Castillo, CE | 1 |
| González-Salinas, CG | 1 |
| Milán-Segovia, RDC | 1 |
| Romano-Moreno, S | 1 |
| Benham, RS | 1 |
| Hewage, NB | 1 |
| Suckow, RF | 1 |
| Engin, E | 1 |
| Rudolph, U | 1 |
| Margiotta-Casaluci, L | 1 |
| Owen, SF | 1 |
| Cumming, RI | 1 |
| de Polo, A | 1 |
| Winter, MJ | 1 |
| Panter, GH | 1 |
| Rand-Weaver, M | 1 |
| Sumpter, JP | 1 |
| Oh, JE | 1 |
| Zupan, B | 1 |
| Gross, S | 1 |
| Toth, M | 1 |
| Thompson, MR | 1 |
| Li, KM | 1 |
| Clemens, KJ | 1 |
| Gurtman, CG | 1 |
| Hunt, GE | 1 |
| Cornish, JL | 1 |
| McGregor, IS | 1 |
5 other studies available for norfluoxetine and Anxiety
| Article | Year |
|---|---|
Factors associated with fluoxetine and norfluoxetine plasma concentrations and clinical response in Mexican patients with mental disorders.
Topics: Adult; Antipsychotic Agents; Anxiety; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome | 2021 |
Prodepressant- and anxiogenic-like effects of serotonin-selective, but not noradrenaline-selective, antidepressant agents in mice lacking α2-containing GABA
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Anxiety; Depression; Desipramine; Dose | 2017 |
Quantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetine.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Behavior, Animal; Biotransformation; Cyp | 2014 |
Paradoxical anxiogenic response of juvenile mice to fluoxetine.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Anxiety; Behavior, Animal; Cell Prolif | 2009 |
Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Body Fluids; Body Temperature; Body Weig | 2004 |